Pharmacy news

• Pharmacists Are Critical Players in Opioid Use Disorder Care

  05-08-2026 12:04 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksA recently signed bill that provides specialized opioid use disorder (OUD) training to pharmacists, coupled with several best-practice models for supporting these patients in a wide range of clinical settings, has underscored the value the profession brings to this challenging condition.Whatever site of care is involved, taking a personalized approach is a key to success, according to Ashley Maister, Pha
  
  Read more

• Insider Access to Patient Records Rose 17% in 2025, Even as Breaches Grew Smaller

  05-08-2026 12:04 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawUnauthorized access to patient records at U.S. healthcare organizations rose 17% year over year in 2025, even as the number of individuals affected fell sharply, according to Bluesight’s 2026 Privacy Trends Report. The number of unauthorized-access incidents grew more frequent, even as each one reached fewer people, with the number affected falling from roughly 16 million in 2024 to just under 2 million
  
  Read more

• SNAP Trial Data Show Benzylpenicillin as a Better Option for Penicillin-Susceptible S. aureus Bacteremia

  05-08-2026 12:03 via pharmacypracticenews.com
  Originally published by our sister publication Infectious Disease Special EditionBy Carlyn AnnunziataBenzylpenicillin was noninferior to the antistaphylococcal penicillin flucloxacillin or cloxacillin in treating penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia, with fewer adverse events, according to new data.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto;
  
  Read more

• Compounding Panel Backs Peptides for the 503A Bulks List, Against FDA Reviewers’ Recommendations

  27-07-2026 11:41 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Marevgenna - stock.adobe.com.Updated 7/27 with ISMP and ECRI statementBy G
  
  Read more

• Advertisement

• Persistent Iron Deficiency Signals Missed Opportunities for Intervention

  24-07-2026 15:24 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Nadzeya, Elena - stock.adobe.com.By Karen BlumMore than half of patients with iron deficiency did not have their condition resolved within a three-ye
  
  Read more

• New Iron Deficiency Guideline Reshapes Oral Dosing and Infusion Protocols

  24-07-2026 15:24 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }©McmahonGroupBy Gina ShawNew consensus guidelines from the Iron Consortium at Oregon Health & Science University (OHSU) recommend major chan
  
  Read more

• IV Iron Infusions Improve Survival for Hospitalized Patients With Sepsis

  24-07-2026 15:24 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Pixel_Studio_8 - stock.adobe.com.By Karen BlumHospitalized patients who have both iron deficiency anemia and sepsis who received IV iron administrati
  
  Read more

• CMS Closes Tardive Dyskinesia Screening Gap for Medicare Plans

  21-07-2026 17:15 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawFor the first time in any Medicare quality program, the Centers for Medicare & Medicaid Services (CMS) is formally encouraging clinicians to screen Medicare patients on antipsychotics for tardive dyskinesia (TD), a condition that affects an estimated 20% to 30% of long-term antipsychotic users but remains substantially underdiagnosed in routine practice (J Clin Psychiatry 2017;78[3]:e264-e278).The change i
  
  Read more

• Advertisement

• Alternative Funding Programs Cause Dangerous Treatment Delays, Drain Patient Assistance Resources

  21-07-2026 17:13 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawA 34-year-old man with stage IV colorectal cancer was responding to treatment when his insurer abruptly stopped covering his medication. What followed consumed five months, required him to obtain a passport, submit to a telehealth visit with a foreign physician he had never met, and ultimately receive his medication from an international pharmacy.The specialty pharmacy team spent roughly 15 hours trying to nav
  
  Read more

• ‘Shadow AI’ in Health Systems: Gaps in Governance Emerge as Use Grows

  21-07-2026 17:11 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawNearly 4 in 10 healthcare professionals surveyed said they’ve encountered institutionally unsanctioned artificial intelligence tools, or so-called “shadow AI,” in hospitals and health systems, and almost 1 in 5 admit to using them themselves. Those are among the findings from a new national Wolters Kluwer Health survey that flags a growing governance gap around AI use in clinical environments
  
  Read more

• How Home Infusion Providers Can Push Back on Payors, PBMs

  21-07-2026 17:10 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawHome infusion providers face four constant challenges with payors and pharmacy benefit managers (PBMs): getting in, getting paid, getting paid enough, and keeping those payments.Jesse Dresser, Esq, a partner in Frier Levitt’s Life Sciences Department who heads the firm’s Pharmacy Practice Group, broke down each pain point and offered practical and legal strategies for protecting revenue streams.&ld
  
  Read more

• PAPs Facing a Perfect Storm In 2026 and Beyond

  21-07-2026 17:08 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawWith a cascade of policy rollbacks, expiring subsidies, and payor-driven benefit changes converging over the next 18 months, PAPs are about to face a perfect storm of disruption.The One Big Beautiful Bill Act (OBBBA), signed into law on July 4, 2025, is already reshaping the insurance landscape. The law did not extend the enhanced Affordable Care Act (ACA) premium tax credits that expired at the end of 2025. &
  
  Read more

• Real-World Evidence Informs Rare Disease Care, Guides New Rx

  21-07-2026 17:07 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksWith fewer than 10% of the world’s roughly 7,000 rare diseases having an approved treatment, the fastest path to new therapies may not run through traditional clinical trials at all—but through the real-world evidence (RWE) from patients already taking these drugs.RWE typically is derived from data collected outside controlled trials (e.g., routine care, registries, and insurance claims). Tif
  
  Read more

• Pharmacy’s Choice: Thrive or Die With AI

  21-07-2026 17:05 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksThe promise and perils of artificial intelligence were the focus of a wide-reaching business session at Asembia’s AXS26 Summit, in Las Vegas.With visionary leadership, AI could potentially transform pharmacy: “You could use AI to cure cancer, to deliver interesting drugs, to remove the drudgery [of daily work],” said Harry Travis, MBA, BSPharm, the president of pharmaceutical consultanc
  
  Read more

• Telehealth Med Management Program Slashes HbA1c Levels

  21-07-2026 17:03 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Karen BlumA pharmacist-led comprehensive medication management telehealth program can achieve significant reductions in hemoglobin A1c (HbA1c) levels among patients with diabetes discharged from the hospital, according to a gold award-winning presentation (poster 153) at AMCP Nexus 2025, in National Harbor, Maryland.Transitions of care from hospital to home are high-risk periods for people with diabetes, said study co-
  
  Read more

• Management of Chorea In Huntington Disease

  21-07-2026 17:02 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumHoney Joseph, PharmD, BCPSClinical Assistant ProfessorClinical Pharmacist, Drug Information CenterUIC Retzky College of PharmacyChicago, IllinoisRita Soni, PharmDClinical Assistant ProfessorClinical Pharmacist, Drug Information CenterUIC Retzky College of PharmacyChicago, IllinoisPreviously termed Huntington’s chorea due to its cardinal presentation of “dance-like” movements, Huntington disease (HD) is t
  
  Read more

• Some Employers Begin Subsidizing Rather Than Covering GLP-1 Drugs

  21-07-2026 17:00 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzWith increasing numbers of employees interested in trying glucagon-like peptide-1 receptor agonist (GLP-1) drugs for weight loss, many employers have found that the high demand has made the cost of insurance coverage for the medications too steep.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; wi
  
  Read more

• ASHP Futures 2025: What is Quiet Cracking?

  17-07-2026 13:09 via pharmacypracticenews.com
  Dr. Michael Wolcott defines quiet cracking and discusses how to address issues before negatively impacting the workplace. 
  
  Read more

• Studies Establish Cutoffs for 2 Environmental Fungi

  13-07-2026 14:43 via pharmacypracticenews.com
  Originally published by our sister publication Infectious Disease Special EditionBy Karen BlumTwo new multicenter studies led by the CDC that were presented at ASM Microbe 2026, in Washington, D.C., have established epidemiological cutoff values (ECVs) against the environmental organisms Purpureocillium lilacinum and Paecilomyces variotii sensu stricto.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:1
  
  Read more

• As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists

  13-07-2026 14:43 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzMedicare’s new Bridge program, which launched on July 1,makes available certain glucagon-like peptide-1 receptor agonist (GLP-1) drugs for a $50 copay, which is hundreds less than the current cash prices for patients not covered for the drugs by insurance.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%;
  
  Read more

• Closing the Expedited Partner Therapy Awareness Gap

  13-07-2026 14:05 via pharmacypracticenews.com
  By Marcus A. BanksPharmacist-led sexually transmitted infection (STI) care at University Hospitals, in Cleveland, is expanding beyond patients to include their sexual partners through expedited partner therapy (EPT), an approach experts said remains underused despite nearly two decades of support from the CDC.At University Hospitals, pharmacists have led STI follow-up and prescribing efforts since 2022 and began offering EPT in January 2025 under Ohio law granting them provider status, according
  
  Read more

• AI Emerges as Powerful PA and 340B Compliance Tool

  13-07-2026 14:01 via pharmacypracticenews.com
  By Gina ShawUniversity Health is using artificial intelligence to transform two of pharmacy’s most labor-intensive functions: navigating prior authorizations (PAs) and ensuring 340B compliance, one of the program’s chief architects noted at the ASHP Pharmacy Futures 2026 meeting, in St. Louis.The PA initiative, developed at University Health, in Kansas City, Missouri, has cut PA review times by more than half, reduced payor decisions from days to hours, and will soon enable its 340B
  
  Read more

• Pharmacist Interventions at 14 SP Sites Avoided $3.6 Million in Costs in 6 Months

  13-07-2026 13:50 via pharmacypracticenews.com
  Pharmacist interventions at 14 health-system specialty pharmacies avoided an estimated $3.6 million in direct medication costs over six months, according to a multisite analysis presented by Vanderbilt Specialty Pharmacy, in Nashville, Tennessee.Vanderbilt leads a consortium of 87 health-system specialty pharmacies, and 14 sites from across the country took part in this analysis. Across those sites, the team prospectively documented pharmacist interventions that led to a medication being discont
  
  Read more

• Navigating the New Complexity of Multiple Myeloma Treatment

  13-07-2026 13:40 via pharmacypracticenews.com
  By Gina ShawJordan Snyder, PharmDFour years ago, VRd (bortezomib, lenalidomide, dexamethasone) was the standard induction regimen for newly diagnosed multiple myeloma. Today, oncology pharmacists are managing quadruplet regimens up front, fielding questions about whether transplant is still necessary, counseling patients through chimeric antigen receptor T-cell (CAR-T) therapy in second-line relapse, and sequencing bispecific T-cell engagers (BiTEs) across a field of four commercially available
  
  Read more

• New ASPEN Guidelines Address Malnutrition Risk in HNC

  13-07-2026 13:36 via pharmacypracticenews.com
  By Susan KreimerThe American Society for Parenteral and Enteral Nutrition (ASPEN) has released new nutrition guidelines for adult patients with head and neck cancer aimed at addressing the many challenges of patient management.The multidisciplinary recommendations “help guide nutrition care across the continuum of treatment—surgery, radiation, chemo, combinations—and emphasize early identification and proactive management of malnutrition,” Whitney Lewis, PharmD, BCOP, who
  
  Read more

• Manufacturer Demand for 340B Claims Data Sets Up Latest Fight

  13-07-2026 13:32 via pharmacypracticenews.com
  By Gina ShawIn early June, Eli Lilly gave an initial group of 340B hospitals five business days to turn over detailed claims-level data or lose access to discounted drug pricing, with ASHP urging federal regulators to step in before the deadline hit.In early July, Lilly raised the stakes by unilaterally cutting critical 340B pricing for safety net hospitals that failed to submit the data, according to an alert ASHP posted to its website. Lilly’s actions “extend beyond the statutory f
  
  Read more

• Taking a BiTE out of Multiple Myeloma

  13-07-2026 13:24 via pharmacypracticenews.com
  By Gina Shaw Kirollos Hanna, PharmDWhen teclistamab-cqyv (Tecvayli, Janssen/Johnson & Johnson) entered the multiple myeloma market at the end of 2022, it signaled the beginning of a new treatment era. For patients who had exhausted four or more prior lines of therapy, the bispecific T-cell engager (BiTE) delivered response rates that the field had never seen before.“These bispecifics have brought an unprecedented therapeutic to our multiple myeloma patients,” said Kirollos Hanna,
  
  Read more

• Older Age Associated With Better Post-Transplant Survival in Newly Diagnosed AML

  09-07-2026 12:35 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzOlder age was independently associated with better post-transplant survival in newly diagnosed acute myeloid leukemia (AML) patients receiving venetoclax (Venclexta, AbbVie/Genentech) and a hypomethylating agent (HMA) (Ven-HMA), according to a presentation at the 2026 ASCO Annual Meeting, in Chicago (abstract 6530). Of note, survival was not associated with genetic profile at the time of allogeneic stem cell
  
  Read more

• Omadacycline Trial Offers a Rare Win for NTM, While Shorter TB Treatment Regimens Are Limited by Toxicities

  08-07-2026 18:40 via pharmacypracticenews.com
  By Gina ShawOmadacycline monotherapy cleared Mycobacterium abscessus from the sputum of 53.8% of patients by day 84 of a phase 2 clinical trial, compared with 25% on placebo, offering the first randomized evidence that a single oral drug can reduce the bacterial burden of a nontuberculous mycobacterial (NTM) infection (Clin Infect Dis 2026 March 3. doi:10.1093/cid/ciag062).figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }fig
  
  Read more

• Rethinking Inpatient IV Default for PWID With Serious Injection-Related Infections

  08-07-2026 18:28 via pharmacypracticenews.com
  By Gina ShawPatient-directed discharge without an oral antibiotic doubles 90-day readmission risk among people who inject drugs (PWID) with serious injection-related infections, Ellen Eaton, MD, MSPH, a professor in the Department of Psychiatry and Medicine at the University of Alabama at Birmingham, told attendees at the newly combined Making a Difference in Infectious Diseases and Society of Infectious Diseases Pharmacists 2026 meeting, in Orlando, Florida.figure { display:inline-block; margin
  
  Read more

• ASHP Futures 2026: Tips for Hazardous Drug Wipe Sampling

  08-07-2026 11:27 via pharmacypracticenews.com
  .secondwrap{font-family:Roboto !important;border:1px solid #a6a6a6;margin-bottom:10px}.secondcontainer{margin-bottom:10px;padding:0px !important}.container-fluid{max-width:1140px;margin-right:auto;margin-left:auto}.ra-img{padding-top:5px;width:80px;height:80px;margin-left:1rem!important}.title{font-size:0.9375rem;font-weight:500;line-height:21px;margin:0px !important}.text{font-size:0.9375rem;line-height:21px;padding-top:5px;padding-bottom:5px;margin:0px}*,::after,::before{box-sizing:border-box}
  
  Read more

• Distinct Mutation Patterns in Black Patients Challenge Current AML Risk Stratification

  07-07-2026 19:26 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzRacial disparities in acute myeloid leukemia (AML) outcomes persist, with Black patients exhibiting distinct molecular biology resulting in diminished prognostic value for traditionally favorable mutations, researchers reported at the 2026 ASCO Annual Meeting, in Chicago (abstract 6534).figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }fig
  
  Read more

• Adult AML Survivors Face Heightened Risk for Additional Cancers

  07-07-2026 19:25 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Cynthia E. KeenAdult acute myeloid leukemia (AML) survivors have a significantly higher risk of developing a second primary cancer in their lifetime compared with the general population, according to data presented at the 2026 ASCO Annual Meeting, in Chicago (abstract 11070). Adults younger than 59 years of age have the highest risk levels (standardized incidence ratio [SIR], 1.91), with higher measures in men (1.37) t
  
  Read more

• Pediatric Iron Deficiency: New Ferritin Thresholds, and a Wider Role for Pharmacy

  07-07-2026 18:26 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }vector juice – stock.adobe.com.By Gina ShawPediatric iron deficiency is being redefined, with significant practical implications for clinicians
  
  Read more

• IV Iron During Acute Infection Linked to Lower Mortality, Real-World Analysis Finds

  07-07-2026 18:21 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Iron IV: anna – stock.adobe.com.By Gina ShawHospitalized adults with iron deficiency anemia (IDA) and an acute bacterial infection who received
  
  Read more

• Action Steps for Reimbursement Readiness

  06-07-2026 17:38 via pharmacypracticenews.com
  Bonnie Kirschenbaum, MS, FASHP,FCSHP“Reimbursement Matters” is a tool for maintaining your health system’s fiscal health. Please email the author at [email protected] with suggestions on reimbursement issues that you would like to see covered.Financial stability remains a critical concern as healthcare organizations navigate 2026 and prepare for fiscal year (FY) 2027, which begins Oct. 1, 2026, for inpatient settings. Calendar year 2027 follows for all other sites of
  
  Read more

• FcRn Inhibition As a Therapeutic Class

  06-07-2026 14:27 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumAmy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaThe treatment landscape for immunoglobulin G (IgG)-mediated autoimmune disease is undergoing a significant shift toward mechanism-driven therapeutics. Management has relied on broad immunosuppression, including cort
  
  Read more

• Compassionate-Use Antifungals: What Clinicians Can Almost Access Now

  06-07-2026 11:37 via pharmacypracticenews.com
  Originally published by our sister publication Infectious Disease Special EditionBy Gina ShawDespite decades of need, antifungal drug development has produced relatively few mechanistically novel agents. Clinicians treating invasive fungal infections continue to rely on three primary classes—azoles, echinocandins, and polyenes—targeting just two major pathways.“We’re actually pretty good at making antifungals. What we struggle with is making good antifungals that are not
  
  Read more

• Emerging Therapies For Blood Cancers

  02-07-2026 19:03 via pharmacypracticenews.com
  Christie Denton, PharmD, BCPSClinical Assistant Professor/Drug Information SpecialistUniversity of Illinois at Chicago College of PharmacyLeukemia, lymphoma, and myeloma, the 3 main types of blood cancers, account for about 10% of new cancer diagnoses each year.1 In 2024, 187,740 new cases of leukemia, lymphoma, and myeloma were estimated to be diagnosed, with approximately 57,260 deaths expected. Advances in treatment for blood cancers have led to guideline updates, expanded indications for sev
  
  Read more

• ASHP Futures 2025: Medication Safety in the AI Era

  30-06-2026 12:53 via pharmacypracticenews.com
  Drs. Sylvia Stoffella and Ben Michaels discuss the potential of their AI pilot project to improve patient safety and assist workflows. 
  
  Read more

• A Plague on Patient Assistance

  23-06-2026 13:47 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawAutumn Zuckerman,PharmDA 34-year-old man with stage IV colorectal cancer was responding to treatment when his insurer abruptly stopped covering his medication. What followed consumed five months, required him to obtain a passport, submit to a telehealth visit with a foreign physician he had never met, and ultimately receive his medication from an international pharmacy.The specialty pharmacy team spent roughly
  
  Read more

• Decnupaz Approved for Blastic Plasmacytoid Dendritic Cell Neoplasms

  23-06-2026 13:44 via pharmacypracticenews.com
  Originally published by our sister publication Clinical Oncology NewsBy Natasha Albaneze, MPHA new treatment option, pivekimab sunirine-pvzy (Decnupaz, AbbVie), has been approved for blastic plasmacytoid dendritic cell neoplasm, a rare type of hematologic malignancy.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:trans
  
  Read more

• ASHP Futures 2026: Proactive Tools to Modernize Medication Safety

  22-06-2026 11:28 via pharmacypracticenews.com
  Dr. Sondra May shares key insights from the 2026 ASHP Pharmacy Forecast and details how shifting from reactive event tracking to a proactive system design will positively impact patient safety. 
  
  Read more

• As Manufacturers Catch On to Alternative Funding Programs, More Specialty Patients Routed to Overseas Pharmacies

  18-06-2026 13:39 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }McMahon PublishingMore drug manufacturers are identifying and rejecting alternative funding program (AFP) applications, pushing commerically insured
  
  Read more

• Ambulatory Care Pharmacists Drive Higher Specialty Prescription Capture

  18-06-2026 13:37 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }pikselstock-stock.adobe.comBy Gina ShawAmbulatory care pharmacists at Yale New Haven Health (YNHH) kept two-thirds of the specialty prescriptions the
  
  Read more

• ASHP Calls on HHS to Halt Lilly’s 340B Data Cutoff

  18-06-2026 12:01 via pharmacypracticenews.com
  Editor's note: Updated 6/18 to reflect cut-off date not yet enacted, plus new comments from Jesse Dresser, Esq., of Frier LevittBy Gina ShawIn early June, Eli Lilly gave an initial group of 340B hospitals five business days to turn over detailed claims-level data or lose access to discounted drug pricing, and ASHP is urging federal regulators to step in before the deadline hit.As of mid-June, the threatened cutoff had not taken effect for many of the covered entities that received the notice, ev
  
  Read more

• ASHP Futures 2026: Recognizing Progress in Precepting

  18-06-2026 11:21 via pharmacypracticenews.com
  This year at ASHP Futures, Dr. Ted Morton received the ASHP Foundation 2025 Pharmacy Residency Excellence Preceptor Award for his over-three decade career in progressing the evolution of pharmacy precepting practices. In this interview with PPN, Dr. Morton discusses what the recognition means to him and shares some of the important lessons and tips he’s learned on how to effectively improve pharmacy residency precepting and training programs. 
  
  Read more

• Revenue Is Critical! Dispel Those Knowledge Gaps!

  18-06-2026 10:34 via pharmacypracticenews.com
  Bonnie Kirschenbaum, MS, FASHP,FCSHP“Reimbursement Matters” is a tool for maintaining your health system’s fiscal health. Please email the author at [email protected] with suggestions on reimbursement issues that you would like to see covered.The Drug Price Competition and Patent Term Restoration Act of 1984 (also known as the Hatch-Waxman Amendments) added sections 505(b)(2) and 505(j) to the Federal Food, Drug, and Cosmetic Act (FD&C Act), establishing abbrevia
  
  Read more

• Pharmacist Interventions at 14 Specialty Pharmacies Avoided $3.6 Million in Costs in 6 Months

  16-06-2026 19:00 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }McMahon PublishingBy Gina ShawPharmacist interventions at 14 health-system specialty pharmacies avoided an estimated $3.6 million in direct medicatio
  
  Read more

• Three-Fourths of Hospital Pharmacies Asked to Reduce Expenses, ASHP Survey Finds

  16-06-2026 18:05 via pharmacypracticenews.com
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }tang90246, stock.adobe.com.By Gina ShawThree-fourths of hospital pharmacy departments have been asked to reduce expenses, and many are trimming staff
  
  Read more

Follow @newsl_pharmacy on Twitter!